RxDoctor Payments Data

Oliver Tannous, MD

Orthopaedic Surgery of the Spine · San Diego, CANPI 1285952655

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $468,801 of the $566,064 with a category attached, or 82.8%. Medacta USA, Inc. accounts for 74.3% of it on its own, with 29 other manufacturers making up the rest. 2025 is the largest year on record at $158,200, more than ten times the $3,488 reported in 2019.

$566,064in general payments, 2019–2025

Across 473 payments — averaging $1196.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medacta USA, Inc.$421K
  • Innovasis Inc$49K
  • Baxter Healthcare$19K
  • Precision Spine, Inc.$17K
  • Centinel Spine, LLC$16K
  • Cerapedics Inc.$15K
  • plus $30K from 24 others

What the payments were for

  • Consulting fees$468,80183%
  • Speaking & faculty fees$5000%
  • Travel & lodging$72,67913%
  • Food & beverage$23,5074%
  • Education$5770%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$566,064 in reported general payments places this provider in the 85th percentile of 288 orthopaedic surgery of the spine providers in California.

See all orthopaedic surgery of the spine providers in California

Medicare billing

Part B allowed, 2024
$454,116
Medicare patients
455
Services billed
1,236

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine34$3,204
Cyclobenzaprine Hcl45$455
Gabapentin38$430
Meloxicam12$44
Alprazolam13$29

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →